QA: Johnson Johnson in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2014_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 56,407,000,000
1 IntangibleAssetsNetIncludingGoodwill 50,745,000,000
2 PropertyPlantAndEquipmentNet 16,710,000,000
3 remainder_Assets 8,821,000,000
4 LiabilitiesCurrent 25,675,000,000
5 LiabilitiesNoncurrent 21,182,000,000
6 remainder_Liabilities 11,773,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,814,134,400
9 ResearchAndDevelopmentExpense 8,175,948,641
10 remainder_Expenses 25,103,424,302
11 remainder_Revenues 71,314,252,943
12 remainder_NetIncome -2,718,917,243
13 remainder_ComprehensiveNetIncome 16,892,889,095
  yvar yval
0 Assets 132,683,000,000
1 Liabilities 58,630,000,000
2 Expenses 55,093,507,343
3 Revenues 71,314,252,943
4 StockholdersEquity 74,053,000,000
5 NetIncome 13,501,828,357
6 ComprehensiveNetIncome 21,948,272,904
7 BaseVar 168,666,283,312
8 EconomicCapitalRatiobeforeLimitedLiability 1.92
9 EconomicCapitalRatio 2.97

Edgar->Model Mapping

Feature Distribution

Change over Time